Daratumumab Provided at Home Experience An Open, Single-center, Mixed-method Project.

Clinical trial NCT05306587 · COMPLETED

Trial details

NCT number: NCT05306587
Sponsor: Thomas Lund
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2022-04-01
Primary completion: 2023-12-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.